Tower Research Capital LLC (Trc) 180 Life Sciences Corp. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.12 - $1.31 $1,884 - $20,576	15,707 New	15,707 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $2.53 $1,994 - $6,228	-2,462 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.53 - $3.9 $98,589 - $151,975	-38,968 Reduced 94.06%	2,462 $6,000
Q4 2021 Feb 14, 2022	BUY	$3.27 - $6.38 $122,523 - $239,052	37,469 Added 945.95%	41,430 $162,000
Q3 2021 Nov 15, 2021	BUY	$5.11 - $10.81 $13,878 - $29,359	2,716 Added 218.15%	3,961 $21,000

Q2 2021 Aug 16, 2021	BUY	$6.7 - $11.98 $8,341 - $14,915	1,245 New	1,245 $12,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $61.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.